The Physics of Discovery.
We are not just automating chemistry; we are digitizing it.
Replacing human intuition with Bayesian Optimization. Replacing pipettes with Acoustic Droplet Ejection. Replacing luck with high-dimensional math.
The Old Way vs The New Way
Linear
- Hypothesis driven. Limited by human bias and cognitive bandwidth.
- Manual Pipetting. High volumetric error. Slow, serial execution.
- Sparse Data. Low throughput compounds/week, statistically insignificant for ML.
Closed-Loop
- Bayesian Optimization. UCB & EI acquisition functions exploring billion-scale spaces.
- Acoustic Ejection. pL precision using sound waves. 1000x faster, zero-contact.
- Active Learning. The model asks for the data it needs most (Highest Uncertainty).
The Closed Loop
Our platform is not a collection of tools; it is an autonomous agent. The output of the assay is the input of the next design.
Design (In Silico)
Generative GFlowNets dream structures. We don't screen libraries; we hallucinate novel chemical matter optimized for potency and solubility simultaneously.
Make (Robotic)
Automated synthesis modules using flow chemistry. Reconfigurable microfluidic reactors that can synthesize, purify, and formulate on demand.
Test (Phenotypic)
High-content cellular imaging. We don't just measure binding; we measure biological reality (cell health, organelle morphology, protein localization).
Analyze (Update)
Negative data is holy. The model updates its belief state. It learns 'what doesn't work' to collapse the search space exponentially.
Cycle Time
In traditional pharma, the Design-Make-Test-Analyze cycle takes weeks or months. We measure it in hours.
Evolution is an iterative algorithm. He who iterates fastest, wins.